Medical Developments International Ltd (MVP) - Net Assets

Latest as of June 2025: AU$55.10 Million AUD ≈ $38.99 Million USD

Based on the latest financial reports, Medical Developments International Ltd (MVP) has net assets worth AU$55.10 Million AUD (≈ $38.99 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$66.40 Million ≈ $46.98 Million USD) and total liabilities (AU$11.29 Million ≈ $7.99 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MVP cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$55.10 Million
% of Total Assets 82.99%
Annual Growth Rate 9.49%
5-Year Change -19.32%
10-Year Change 189.64%
Growth Volatility 28.66

Medical Developments International Ltd - Net Assets Trend (2003–2025)

This chart illustrates how Medical Developments International Ltd's net assets have evolved over time, based on quarterly financial data. Also explore MVP asset base for the complete picture of this company's asset base.

Annual Net Assets for Medical Developments International Ltd (2003–2025)

The table below shows the annual net assets of Medical Developments International Ltd from 2003 to 2025. For live valuation and market cap data, see Medical Developments International Ltd stock valuation.

Year Net Assets Change
2025-06-30 AU$55.10 Million
≈ $38.99 Million		 +20.49%
2024-06-30 AU$45.73 Million
≈ $32.36 Million		 -43.76%
2023-06-30 AU$81.31 Million
≈ $57.54 Million		 +41.92%
2022-06-30 AU$57.30 Million
≈ $40.54 Million		 -16.11%
2021-06-30 AU$68.30 Million
≈ $48.33 Million		 +57.60%
2020-06-30 AU$43.34 Million
≈ $30.66 Million		 -2.80%
2019-06-30 AU$44.59 Million
≈ $31.55 Million		 +111.91%
2018-06-30 AU$21.04 Million
≈ $14.89 Million		 -2.59%
2017-06-30 AU$21.60 Million
≈ $15.28 Million		 +13.53%
2016-06-30 AU$19.02 Million
≈ $13.46 Million		 +9.30%
2015-06-30 AU$17.41 Million
≈ $12.32 Million		 +10.00%
2014-06-30 AU$15.82 Million
≈ $11.20 Million		 +0.60%
2013-06-30 AU$15.73 Million
≈ $11.13 Million		 -2.72%
2012-06-30 AU$16.17 Million
≈ $11.44 Million		 +11.86%
2011-06-30 AU$14.46 Million
≈ $10.23 Million		 +13.71%
2010-06-30 AU$12.71 Million
≈ $8.99 Million		 +7.60%
2009-06-30 AU$11.81 Million
≈ $8.36 Million		 +0.11%
2008-06-30 AU$11.80 Million
≈ $8.35 Million		 +7.08%
2007-06-30 AU$11.02 Million
≈ $7.80 Million		 +11.64%
2006-06-30 AU$9.87 Million
≈ $6.99 Million		 +17.52%
2005-06-30 AU$8.40 Million
≈ $5.94 Million		 +0.31%
2004-06-30 AU$8.37 Million
≈ $5.93 Million		 +11.62%
2003-06-30 AU$7.50 Million
≈ $5.31 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Medical Developments International Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 6276500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$115.01 Million 208.71%
Other Comprehensive Income AU$2.86 Million 5.19%
Other Components AU$1.00 0.00%
Total Equity AU$55.10 Million 100.00%

Medical Developments International Ltd Competitors by Market Cap

The table below lists competitors of Medical Developments International Ltd ranked by their market capitalization.

Company Market Cap
Bluecom Co. Ltd
KQ:033560
 $37.87 Million
Berlina Tbk
JK:BRNA
 $37.87 Million
Aurumin Ltd
AU:AUN
 $37.88 Million
Kisan Telecom Co. Ltd
KQ:035460
 $37.89 Million
BioRem Inc.
V:BRM
 $37.86 Million
Agrometal S.A.I.
BA:AGRO
 $37.86 Million
Rhone Ma Holdings Bhd
KLSE:5278
 $37.86 Million
Soktas Tekstil Sanayi ve Ticaret AS
IS:SKTAS
 $37.85 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Medical Developments International Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 45,734,000 to 55,104,000, a change of 9,370,000 (20.5%).
  • Net income of 94,000 contributed positively to equity growth.
  • Share repurchases of 304,000 reduced equity.
  • New share issuances of 10,014,000 increased equity.
  • Other comprehensive income decreased equity by 2,001.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$94.00K +0.17%
Share Repurchases AU$304.00K -0.55%
Share Issuances AU$10.01 Million +18.17%
Other Comprehensive Income AU$-2.00K -0.0%
Other Changes AU$-432.00K -0.78%
Total Change AU$- 20.49%

Book Value vs Market Value Analysis

This analysis compares Medical Developments International Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.97x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 3.67x to 0.97x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2003-06-30 AU$0.13 AU$0.48 x
2004-06-30 AU$0.18 AU$0.48 x
2005-06-30 AU$0.15 AU$0.48 x
2006-06-30 AU$0.17 AU$0.48 x
2007-06-30 AU$0.19 AU$0.48 x
2008-06-30 AU$0.20 AU$0.48 x
2009-06-30 AU$0.21 AU$0.48 x
2010-06-30 AU$0.24 AU$0.48 x
2011-06-30 AU$0.28 AU$0.48 x
2012-06-30 AU$0.30 AU$0.48 x
2013-06-30 AU$0.28 AU$0.48 x
2014-06-30 AU$0.27 AU$0.48 x
2015-06-30 AU$0.30 AU$0.48 x
2016-06-30 AU$0.33 AU$0.48 x
2017-06-30 AU$0.37 AU$0.48 x
2018-06-30 AU$0.36 AU$0.48 x
2019-06-30 AU$0.68 AU$0.48 x
2020-06-30 AU$0.65 AU$0.48 x
2021-06-30 AU$0.98 AU$0.48 x
2022-06-30 AU$0.79 AU$0.48 x
2023-06-30 AU$0.96 AU$0.48 x
2024-06-30 AU$0.53 AU$0.48 x
2025-06-30 AU$0.49 AU$0.48 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Medical Developments International Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.17%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.24%
  • • Asset Turnover: 0.59x
  • • Equity Multiplier: 1.20x
  • Recent ROE (0.17%) is above the historical average (-0.43%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 5.74% 15.78% 0.24x 1.49x AU$-356.40K
2005 2.00% 3.11% 0.47x 1.38x AU$-672.00K
2006 8.07% 12.07% 0.53x 1.27x AU$-190.20K
2007 10.95% 16.32% 0.61x 1.10x AU$104.90K
2008 7.55% 9.66% 0.70x 1.12x AU$-289.10K
2009 6.86% 9.28% 0.65x 1.13x AU$-371.40K
2010 6.91% 10.60% 0.58x 1.12x AU$-392.20K
2011 12.06% 17.08% 0.61x 1.16x AU$297.50K
2012 16.72% 23.90% 0.59x 1.18x AU$1.09 Million
2013 14.68% 19.68% 0.58x 1.29x AU$736.10K
2014 5.53% 9.34% 0.42x 1.43x AU$-707.40K
2015 8.78% 13.17% 0.50x 1.32x AU$-211.70K
2016 8.25% 10.14% 0.38x 2.17x AU$-333.50K
2017 8.43% 9.92% 0.44x 1.93x AU$-340.00K
2018 1.15% 1.39% 0.35x 2.35x AU$-1.86 Million
2019 2.33% 4.97% 0.25x 1.90x AU$-3.42 Million
2020 0.87% 1.68% 0.24x 2.19x AU$-3.95 Million
2021 -18.40% -49.72% 0.25x 1.47x AU$-19.40 Million
2022 -21.65% -56.54% 0.22x 1.77x AU$-18.14 Million
2023 -6.90% -17.35% 0.30x 1.35x AU$-13.74 Million
2024 -89.63% -123.66% 0.56x 1.29x AU$-45.57 Million
2025 0.17% 0.24% 0.59x 1.20x AU$-5.42 Million

Industry Comparison

This section compares Medical Developments International Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $33,737,892
  • Average return on equity (ROE) among peers: -43.81%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Medical Developments International Ltd (MVP) AU$55.10 Million 5.74% 0.20x $37.86 Million
Althea Group Holdings Ltd (AGH) $-574.00K 0.00% 0.00x $12.05 Million
BOD Science Ltd (BOD) $2.62 Million -140.23% 0.46x $3.01 Million
BPH Global Ltd (BP8) $4.72 Million -74.95% 0.62x $2.62 Million
Cann Group Ltd (CAN) $59.26 Million -57.02% 1.18x $5.62 Million
ECS Botanics Holdings Ltd (ECS) $1.50 Million -98.58% 0.21x $5.65 Million
Ecofibre Ltd (EOF) $109.94 Million -13.34% 0.36x $5.36 Million
Epsilon Healthcare Ltd (EPN) $28.09 Million -30.66% 0.17x $5.51 Million
Elixinol Wellness Ltd (EXL) $99.42 Million 0.00% 0.04x $2.05 Million
IDT Australia Ltd (IDT) $27.61 Million 7.62% 0.24x $12.10 Million
Invion Ltd (IVX) $4.79 Million -30.96% 0.18x $3.76 Million

About Medical Developments International Ltd

AU:MVP Australia Drug Manufacturers - Specialty & Generic
Market Cap
$37.86 Million
AU$53.51 Million AUD
Market Cap Rank
#22881 Global
#878 in Australia
Share Price
AU$0.48
Change (1 day)
+7.95%
52-Week Range
AU$0.37 - AU$0.76
All Time High
AU$11.06
Categories
Companies in Australia Drug Manufacturers - Specialty & Generic
About

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more